| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 3, 2026 | Sell(S) | 800 | $93.97 | $75K | 582K |
| Aug 3, 2026 | Sell(S) | 7K | $95.10 | $681K | 575K |
| Aug 3, 2026 | Sell(S) | 6K | $95.93 | $541K | 569K |
| Aug 3, 2026 | Sell(S) | 1K | $96.82 | $135K | 568K |
| Aug 3, 2026 | Sell(S) | 16 | $97.46 | $2K | 568K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001636282-26-000099) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Spyre Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.